rs9324685

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000405.5(GM2A):​c.*28C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0496 in 1,613,684 control chromosomes in the GnomAD database, including 4,353 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.089 ( 1089 hom., cov: 32)
Exomes 𝑓: 0.046 ( 3264 hom. )

Consequence

GM2A
NM_000405.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.35
Variant links:
Genes affected
GM2A (HGNC:4367): (ganglioside GM2 activator) This gene encodes a small glycolipid transport protein which acts as a substrate specific co-factor for the lysosomal enzyme beta-hexosaminidase A. Beta-hexosaminidase A, together with GM2 ganglioside activator, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene result in GM2-gangliosidosis type AB or the AB variant of Tay-Sachs disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 5-151267479-C-T is Benign according to our data. Variant chr5-151267479-C-T is described in ClinVar as [Benign]. Clinvar id is 256029.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.247 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GM2ANM_000405.5 linkuse as main transcriptc.*28C>T 3_prime_UTR_variant 4/4 ENST00000357164.4
GM2ANM_001167607.3 linkuse as main transcriptc.413-13C>T splice_polypyrimidine_tract_variant, intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GM2AENST00000357164.4 linkuse as main transcriptc.*28C>T 3_prime_UTR_variant 4/41 NM_000405.5 P1

Frequencies

GnomAD3 genomes
AF:
0.0888
AC:
13508
AN:
152092
Hom.:
1086
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.193
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.0683
Gnomad ASJ
AF:
0.0276
Gnomad EAS
AF:
0.259
Gnomad SAS
AF:
0.0968
Gnomad FIN
AF:
0.0398
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0294
Gnomad OTH
AF:
0.0699
GnomAD3 exomes
AF:
0.0716
AC:
17956
AN:
250922
Hom.:
1252
AF XY:
0.0684
AC XY:
9279
AN XY:
135632
show subpopulations
Gnomad AFR exome
AF:
0.200
Gnomad AMR exome
AF:
0.0705
Gnomad ASJ exome
AF:
0.0289
Gnomad EAS exome
AF:
0.258
Gnomad SAS exome
AF:
0.0850
Gnomad FIN exome
AF:
0.0441
Gnomad NFE exome
AF:
0.0301
Gnomad OTH exome
AF:
0.0473
GnomAD4 exome
AF:
0.0455
AC:
66567
AN:
1461474
Hom.:
3264
Cov.:
34
AF XY:
0.0460
AC XY:
33477
AN XY:
727046
show subpopulations
Gnomad4 AFR exome
AF:
0.198
Gnomad4 AMR exome
AF:
0.0692
Gnomad4 ASJ exome
AF:
0.0289
Gnomad4 EAS exome
AF:
0.250
Gnomad4 SAS exome
AF:
0.0854
Gnomad4 FIN exome
AF:
0.0439
Gnomad4 NFE exome
AF:
0.0292
Gnomad4 OTH exome
AF:
0.0630
GnomAD4 genome
AF:
0.0889
AC:
13528
AN:
152210
Hom.:
1089
Cov.:
32
AF XY:
0.0908
AC XY:
6759
AN XY:
74412
show subpopulations
Gnomad4 AFR
AF:
0.193
Gnomad4 AMR
AF:
0.0680
Gnomad4 ASJ
AF:
0.0276
Gnomad4 EAS
AF:
0.259
Gnomad4 SAS
AF:
0.0967
Gnomad4 FIN
AF:
0.0398
Gnomad4 NFE
AF:
0.0294
Gnomad4 OTH
AF:
0.0691
Alfa
AF:
0.0511
Hom.:
155
Bravo
AF:
0.0954
Asia WGS
AF:
0.160
AC:
556
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicDec 16, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 18, 2019- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Tay-Sachs disease, variant AB Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
7.9
DANN
Benign
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs9324685; hg19: chr5-150647040; COSMIC: COSV64095301; COSMIC: COSV64095301; API